Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04356027 · ClinicalTrials.gov registry record
FUnctional diagnoSIs of corONary Stenosis (FUSION)
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 312
- Enrollment target
NCT04356027 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 312 participants.
The verdict
NCT04356027 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 312 participants
- Enrollment target
Study Summary
The purpose of the FUSION study is to validate the diagnostic performance of Virtual Flow Reserve (VFR) by comparing it against a reference standard, fractional flow reserve (FFR).
Interventions
- PROCEDURE FFR
- PROCEDURE ICA (Invasive Coronary Angiography)
- PROCEDURE OCT
- OTHER VFR Analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2020-06-26 |
| Est. Completion | 2021-10-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04356027
The ClinicalTrials.gov registry entry for NCT04356027 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 312 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which FFR is the first listed.
NCT04356027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04356027 about?
NCT04356027 is a clinical study titled "FUnctional diagnoSIs of corONary Stenosis (FUSION)". The purpose of the FUSION study is to validate the diagnostic performance of Virtual Flow Reserve (VFR) by comparing it against a reference standard, fractional flow reserve (FFR).
What is the current status of trial NCT04356027?
This trial is currently completed. The enrollment target is 312 participants. The study started on 2020-06-26. Estimated completion is 2021-10-15.
What interventions are being tested in trial NCT04356027?
The interventions under investigation include: FFR (PROCEDURE), ICA (Invasive Coronary Angiography) (PROCEDURE), OCT (PROCEDURE), VFR Analysis (OTHER).
Who is sponsoring clinical trial NCT04356027?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.